You are here

  • Home
  • Archive
  • Volume 73, Issue 8
  • The issue of bioavailability of oral low dose methotrexate: should we choose only 10 mg of MTX a week in conjunction with anti-TNF therapy?

Article Text

Article menu
Download PDFPDF
Electronic pages
Correspondence
The issue of bioavailability of oral low dose methotrexate: should we choose only 10 mg of MTX a week in conjunction with anti-TNF therapy?

https://doi.org/10.1136/annrheumdis-2014-205701

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles

    • Electronic pages
      Response to H Zeidler's comments on the CONCERTO study
      Gerd R Burmester Alan Kivitz Hartmut Kupper Udayasankar Arulmani Stefan Florentinus Sandra L Goss Suchitrita S Rathmann Roy M Fleischmann
      Annals of the Rheumatic Diseases 2014; 73 e51-e51 Published Online First: 09 Jun 2014. doi: 10.1136/annrheumdis-2014-205704